Dehydroepiandrosterone sulfate and postmenopausal women

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 18, Issue 3, 2011, Pages 171-176

  Goel, Rachna M ^a   Cappola, Anne R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aging; dehydroepiandrosterone; postmenopausal; women

Indexed keywords

CALCIUM; PRASTERONE SULFATE; VITAMIN D;

ARTICLE; BONE DENSITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; DRUG EFFECT; DRUG SAFETY; HEART ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; POSTMENOPAUSE; SEXUAL FUNCTION; SUPRAVENTRICULAR PREMATURE BEAT;

ATROPHY; BONE DENSITY; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DEHYDROEPIANDROSTERONE SULFATE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; POSTMENOPAUSE; RISK; VAGINA;

EID: 79955631457     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283461818     Document Type: Article

References (33)

1. Labrie F. DHEA, important source of sex steroids in men and even more in women. Prog Brain Res 2010; 182:97-148.
2. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984; 59:551-555. (Pubitemid 14031806)
3. Auchus RJ. Overview of dehydroepiandrosterone biosynthesis. Semin Reprod Med 2004; 22:281-288. (Pubitemid 40030078)
4. Widstrom RL, Dillon JS. Is there a receptor for dehydroepiandrosterone or dehydroepiandrosterone sulfate? Semin Reprod Med 2004; 22:289-298. (Pubitemid 40030079)
5. Enomoto M, Adachi H, Fukami A, et al. Serum dehydroepiandrosterone sulfate levels predict longevity in men: 27-year follow-up study in a community-based cohort (Tanushimaru study). J Am Geriatr Soc 2008; 56:994-998. (Pubitemid 351782716)
6. Phillips AC, Carroll D, Gale CR, et al. Cortisol, DHEA sulphate, their ratio, and all-cause and cause-specific mortality in the Vietnam Experience Study. Eur J Endocrinol 2010; 163:285-292.
7. Cappola AR, O'Meara ES, Guo W, et al. Trajectories of dehydroepiandrosterone sulfate predict mortality in older adults: The Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci 2009; 64:1268-1274. An observational study of 950 elderly men and women showing that individuals with a steeper decline in DHEA-S levels or extreme variability in levels have a higher mortality rate, whereas baseline DHEA-S levels were not associated with mortality.
8. Rice SP, Agarwal N, Bolusani H, et al. Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: A randomized crossover trial. J Clin Endocrinol Metab 2009; 94:1966-1972.
9. Srinivasan M, Irving BA, Frye RL, et al. Effects on lipoprotein particles of longterm dehydroepiandrosterone in elderly men and women and testosterone in elderly men. J Clin Endocrinol Metab 2010; 95:1617-1625. A randomized, double-blind, placebo-controlled trial of long-term DHEA supplementation in elderly women showing a reduction in HDL concentrations and number of HDL particles.
10. Boxer RS, Kleppinger A, Brindisi J, et al. Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics. Age Ageing 2010; 39:451-458.
11. Jankowski CM, Gozansky WS, Kittelson JM, et al. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens. J Clin Endocrinol Metab 2008; 93:4767-4773. A randomized, double-blind, placebo-controlled study of long-term DHEA treatment in elderly women showing significant improvement in hip BMD, which was mediated by serum estradiol.
12. Weiss EP, Shah K, Fontana L, et al. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr 2009; 89:1459-1467.
13. Kenny AM, Boxer RS, Kleppinger A, et al. Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J Am Geriatr Soc 2010; 58:1707-1714.
14. Panjari M, Bell RJ, Jane F, et al. A randomized trial of oral DHEA treatment for sexual function, well being, and menopausal symptoms in postmenopausal women with low libido. J Sex Med 2009; 6:2579-2590.
15. Labrie F, Archer D, Bouchard C, et al. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause 2009; 16:907-922. A randomized, double-blind, placebo-controlled trial showing that intravaginally administered DHEA improved sexual function and signs and symptoms of vaginal atrophy.
16. Kritz-Silverstein D, von Muhlen D, Laughlin GA, Bettencourt R. Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: The DHEA and Well Ness (DAWN) Trial. J Am Geriatr Soc 2008; 56:1292-1298.
17. Yamada S, Masahiro A, Fukai S, et al. Effects of deydroepiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairment. Geriatr Gerontol Int 2010; 10:280-287.
18. Shufelt C, Bretsky P, Almeida CM, et al. DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute (NHLBI)- sponsored Women's Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab 2010; 95:4985-4992.
19. Sanders JL, Boudreau RM, Cappola AR, et al. Cardiovascular disease is associated with greater incident dehydroepiandrosterone sulfate decline in the oldest old: The cardiovascular health study all stars study. J AmGeriatr Soc 2010; 58:421-426.
20. Altman R, Motton DD, Kota RS, Rutledge JC. Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: Roles of PPARalpha and NF-kappaB. Vasc Pharmacol 2008; 48:76-84.
21. Kanazawa I, Yamaguchi T, Yamamoto M, et al. Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitus. Endocr J 2008; 55:667-675.
22. Naessen T, Sjogren U, Bergquist J, et al. Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women. J Clin Endocrinol Metab 2010; 95:1889-1897.
23. Casson PR, Toth MJ, Johnson JV, et al. Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women. J Clin Endocrinol Metab 2010; 95:4276-4282.
24. Nair KS, Rizza RA, O'Brien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006; 355:1647-1659. (Pubitemid 44583955)
25. Jankowski CM, Gozansky WS, Schwartz RS, et al. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: A randomized, controlled trial. J Clin Endocrinol Metab 2006; 91:2986-2993. (Pubitemid 44271746)
26. Sanders JL, Cappola AR, Arnold AM, et al. Concurrent change in dehydroepiandrosterone sulfate and functional performance in the oldest old: Results from the Cardiovascular Health Study All Stars study. J Gerontol A Biol Sci Med Sci 2010; 65:976-981.
27. Panjari M, Davis SR. DHEA therapy for women: Effect on sexual function and wellbeing. Hum Reprod Update 2007; 13:239-248. (Pubitemid 47071610)
28. Labrie F, Archer D, Bouchard C, et al. High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy. Gynecol Endocrinol 2010; 26:524-532.
29. Labrie F, Archer D, Bouchard C, et al. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause 2009; 16:897-906.
30. Naylor JC, Hulette CM, Steffens DC, et al. Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage. J Clin Endocrinol Metab 2008; 93:3173-3178.
31. Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999; 341:1013-1020. (Pubitemid 29451796)
32. Sahelian R, Borken S. Dehydroepiandrosterone and cardiac arrhythmia. Ann Intern Med 1998; 129:588.
33. Parasrampuria J, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement products. JAMA 1998; 280:1565. (Pubitemid 28520637)